Nationwide epidemiological survey of primary Sjogren’s disease in Japan using the National Database of Designated Intractable Diseases
Modern Rheumatology · 2025
DOI: 10.1093/mr/roaf027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Yuzaburo Inoue und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medical Science, Graduate School of Medicine, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: Sjogren's Syndrome. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Objectives
This study aimed to evaluate clinical and serological factors influencing systemic disease activity in primary Sjögren’s disease (SjD) using the European League Against Rheumatism Sjögren’s Syndrome Disease Activity Index (ESSDAI) and to identify distinct patient subgroups in a Japanese cohort.
Methods
Data from 7444 patients with ESSDAI ≥5 registered in Japan’s National Database of Designated Intractable Diseases were analysed. Univariate and multivariate regression analyses evaluated the impact of demographic and serological factors on ESSDAI scores. K-means clustering identified subgroups based on significant variables.
Results
Male patients exhibited higher ESSDAI scores (coefficient: 0.76, P = .0007), whereas Hashimoto’s disease was associated with lower scores (coefficient: −0.53, P = .009). Anti-SS-B/La (coefficient: 1.08, P = .0002) and high titre of antinuclear antibody (ANA) (coefficient: 0.64, P = .02) were associated with increased ESSDAI. Clustering identified three subgroups: a ‘classic’ SjD group with balanced systemic involvement, a male-specific group with severe manifestations, and a Hashimoto’s disease group with milder activity.
Conclusions
Primary SjD in Japan exhibits significant heterogeneity influenced by demographic and serological factors. Male sex and specific autoantibodies correlate with higher systemic activity, whereas Hashimoto’s disease is associated with reduced severity. These findings elucidate the need for personalised management and longitudinal studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Medical Science, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Department of Paediatrics, Eastern Chiba Medical Centre, Chiba, Japan.
- Department of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan.
- Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan.
- Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
- Showa University Research Administration Centre, Showa University, Tokyo, Japan.
ORCID-Profile: Yuzaburo Inoue
Zitieren
APA
Inoue, Y., Sakai, R., Inoue, E., Mitsunaga, K., Yamaji, K., Mori, M., Tomiita, M., Shimojo, N., & Miyamae, T. (2025). Nationwide epidemiological survey of primary Sjogren’s disease in Japan using the National Database of Designated Intractable Diseases. Modern Rheumatology. https://doi.org/10.1093/mr/roaf027
Vancouver
Inoue Y, Sakai R, Inoue E, Mitsunaga K, Yamaji K, Mori M, et al. Nationwide epidemiological survey of primary Sjogren’s disease in Japan using the National Database of Designated Intractable Diseases. Modern Rheumatology. 2025. doi:10.1093/mr/roaf027
BibTeX
@article{Inoue2025,
author = {Inoue, Yuzaburo and Sakai, Ryoko and Inoue, Eisuke and Mitsunaga, Kanako and Yamaji, Ken and Mori, Masaaki and Tomiita, Minako and Shimojo, Naoki and Miyamae, Takako},
title = {Nationwide epidemiological survey of primary Sjogren’s disease in Japan using the National Database of Designated Intractable Diseases},
journal = {Modern Rheumatology},
year = {2025},
doi = {10.1093/mr/roaf027}
}
EUVIMED